
GLP-1 weight-loss jabs reshape British shopping habits
Weight-loss injections are changing UK spending patterns: about 1.6 million people used GLP-1 weight-loss jabs in 2024, with private users paying over £300 a month. Users report smaller grocery bills due to reduced appetite and a shift toward nutrient-dense, protein-rich foods, while some still face high drug costs. Dining out and takeaway purchases are down, alcohol intake is dropping for some, and fashion and fitness sectors see increased activity as people replace wardrobes and invest in wellness. The overall effect is a pivot toward health-focused spending, with costs influenced by the drugs themselves.





